Extensive in vitro and in vivo studies have demonstrated its capacity to inhibit tumor initiation and progression through multiple mechanisms, including COX-2 inhibition [15], modulation of 5-lipoxygenase signaling [16], and induction of apoptosis via Bax upregulation and caspase activation [17]. This evidence concerns the gene BAX and neoplasm.